# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Canertinib (CI-1033) | 18 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
2. | Sorafenib | 5 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
3. | Nilotinib (AMN-107) | 38 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
4. | GSK690693 | 3g, GSK-690693 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
5. | AT7519 | 33 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
6. | Bosutinib Isomer 1, Free Base | 1 (SKI-606) | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
7. | MLN8054 | MLN-8054 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
8. | GSK461364 | GSK-461364A | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
9. | RAF265 (CHIR-265) | CHIR-265/RAF-265 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
10. | AST-487 (NVP-AST487) | AST-487 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
11. | SGX-523 | SGX-523 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
12. | Tandutinib (MLN518) | 75 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
13. | ALA522892 | 5 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
14. | Motesanib | AMG-706 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
15. | SB-203580 | 9 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
16. | GSK1838705A | 40 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
17. | Lestaurtinib | CEP-701 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
18. | Axitinib | AG-13736 | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
19. | MLN120B | ML120B | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens | |||
20. | Gefitinib (ZD1839) | Iressa | Kd | > | 10000 | nM | ALA1908410 | nM | Homo sapiens |